This brand name is authorized in Australia, Austria, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey.
The drug UROMITEXAN contains one active pharmaceutical ingredient (API):
1
|
UNII
NR7O1405Q9 - MESNA
|
|
Mesna is an antidote, and offers the possibility of reliably preventing urotoxic side-effects associated with aggressive cancer chemotherapy using oxazaphosphorine cytostatics. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| V03AF01 | Mesna | V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AF Detoxifying agents for antineoplastic treatment |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 5960Q, 5961R, 8078E, 8079F |
| CA | Health Products and Food Branch | 02241411, 02371839 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 27.359-11-06 |
| EE | Ravimiamet | 1078534 |
| ES | Centro de información online de medicamentos de la AEMPS | 83869s |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 082237, 111863, 409205, 464876, 537908, 551790 |
| FR | Base de données publique des médicaments | 62740395, 66310626, 66428507, 66889194, 69566673 |
| HK | Department of Health Drug Office | 14788 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-884214539 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 7737 |
| JP | 医薬品医療機器総合機構 | 3929406A1020, 3929406A2026 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1004000 |
| MT | Medicines Authority | MA1277/00901, MA1277/00902 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 403M90 |
| NL | Z-Index G-Standaard | 12312053, 13915460 |
| NL | Z-Index G-Standaard, PRK | 15776, 41866, 43761, 43788 |
| NZ | Medicines and Medical Devices Safety Authority | 4986, 4987, 4988 |
| PL | Rejestru Produktów Leczniczych | 100069431, 100414810, 100441221 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W04133001 |
| SG | Health Sciences Authority | 05694P, 10703P, 10704P |
| TN | Direction de la Pharmacie et du Médicament | 2613021H |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8681413881411 |
| ZA | Health Products Regulatory Authority | 29/18/0355, 29/18/0356, S/18/304, S/18/305, S/18/306, S/18/307 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.